Tech Company Financing Transactions

Profectus BioSciences Funding Round

Profectus BioSciences, operating out of Baltimore, secured $3 million from Cross Atlantic Capital Partners.

Transaction Overview

Announced On
5/31/2006
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Proceeds Purpose
The new financing will be used to start clinical trials later this year on potential treatments developed from this technology

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6411 Beckley St.
Baltimore, MD 21224
USA
Email Address
Overview
Profectus BioSciences, Inc. identifies and commercializes technologies intended to reduce the morbidity and mortality caused by viral diseases, especially Human Immunodeficiency Virus (HIV).
Profile
Profectus BioSciences LinkedIn Company Profile
Social Media
Profectus BioSciences Company Twitter Account
Company News
Profectus BioSciences News
Facebook
Profectus BioSciences on Facebook
YouTube
Profectus BioSciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
Thomas Paese
  Thomas Paese LinkedIn Profile  Thomas Paese Twitter Account  Thomas Paese News  Thomas Paese on Facebook
Chief Operating Officer
Jeffrey Meshulam
  Jeffrey  Meshulam LinkedIn Profile  Jeffrey  Meshulam Twitter Account  Jeffrey  Meshulam News  Jeffrey  Meshulam on Facebook
Chief Scientific Officer
John Eldridge
  John  Eldridge LinkedIn Profile  John  Eldridge Twitter Account  John  Eldridge News  John  Eldridge on Facebook
VP - Operations
Terry Higgins
  Terry Higgins LinkedIn Profile  Terry Higgins Twitter Account  Terry Higgins News  Terry Higgins on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/31/2006: FoldRx Pharmaceuticals venture capital transaction
Next: 5/31/2006: Breach Security venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary